Enanta Pharmaceuticals
ENTA
#7512
Rank
C$0.56 B
Marketcap
C$19.47
Share price
-1.60%
Change (1 day)
58.99%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -C$0.13 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are C$64.8 Million. In 2024 the company made an earning of -C$0.14 Billion, an increase over its 2023 earnings that were of -C$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.13 Billion-9.9%
2024 -C$0.14 Billion-23.87%
2023 -C$0.18 Billion4.39%
2022 -C$0.17 Billion-4.4%
2021 -C$0.18 Billion91.12%
2020 -C$92 Million-407.13%
2019 C$29.95 M-78.63%
2018 C$0.14 B117.97%
2017 C$64.31 M-574.65%
2016 -C$13.55 Million-110.83%
2015 C$0.12 B-4.5%
2014 C$0.13 B-638.53%
2013 -C$24.34 Million-137.98%
2012 C$64.06 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
C$2.28 B-2,025.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.61 B-37,685.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$6.14 B-5,276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.79 B-26,889.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.06 B-9,419.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.60 B-19,149.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland